Advertisement
Canada markets closed
  • S&P/TSX

    22,308.93
    -66.90 (-0.30%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CAD/USD

    0.7317
    +0.0006 (+0.08%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • Bitcoin CAD

    83,226.35
    -2,885.83 (-3.35%)
     
  • CMC Crypto 200

    1,259.02
    -98.99 (-7.29%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • RUSSELL 2000

    2,059.78
    -13.85 (-0.67%)
     
  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     
  • NASDAQ

    16,340.87
    -5.40 (-0.03%)
     
  • VOLATILITY

    12.55
    -0.14 (-1.10%)
     
  • FTSE

    8,433.76
    +52.41 (+0.63%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • CAD/EUR

    0.6789
    +0.0011 (+0.16%)
     

Aphria Stock: Analyst Recommendations and Target Prices

Aphria Stock: Analyst Recommendations and Target Prices

Aphria (APHQF) is one of the top medical cannabis licensed producers in Canada. It closed at 11.75 Canadian dollars, which was far from 20.19 Canadian dollars at the start of this year. To see how Aphria compares with companies (HMMJ) such as Aurora Cannabis (ACB) and Canopy Growth (WEED) (CGC), read Comparing Major Cannabis Players’ Prices and Cost Structures.